Phase I trial of weekly irinotecan combined with UFT as second-line treatment for advanced colorectal cancer
- 1 December 2001
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 37 (18) , 2385-2391
- https://doi.org/10.1016/s0959-8049(01)00321-5
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- CPT-11 in gastrointestinal cancerEuropean Journal Of Cancer, 1999
- Phase I Trial ofU racil-Tegafur (UFT) plus Oral Leucovorin: 28-Day ScheduleCancer Investigation, 1998
- A comprehensive review of 5-fluorouracil and leucovorin in patients with metastatic colorectal carcinomaCancer, 1997
- Phase I trials of uracil-tegafur (UFT) using 5 and 28 day administration schedulesAnti-Cancer Drugs, 1996
- Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.Journal of Clinical Oncology, 1996
- CPT-11 (Irinotecan) in the treatment of colorectal cancerEuropean Journal Of Cancer, 1995
- Comparison of Topoisomerase I Inhibition, DNA Damage, and Cytotoxicity of Camptothecin Derivatives Presently in Clinical TrialsJNCI Journal of the National Cancer Institute, 1994
- Chemotherapy for Colorectal CancerNew England Journal of Medicine, 1994
- Topoisomerase I inhibitors: topotecan and irenotecanCancer Treatment Reviews, 1994
- The chemotherapy of colon cancer can no longer be ignoredEuropean Journal Of Cancer, 1993